Celsion Corporation to Participate in Two Investor Conferences in May 2019   Company to Discuss its Ongoing Pivotal Phase III Study in Primary Liver Cancer and its Phase I/II Clinical Study in Ovarian Cancer LAWRENCEVILLE, N.J., April 12, 2019 (GLOBE NEWSWIRE) --  Celsion...